Latest Innovative Molecules News & Updates

See the latest news and media coverage for Innovative Molecules. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Innovative Molecules

Biopharmaceutical company developing antiviral treatments for herpes-related diseases

innovativemolecules.com

Last updated

Latest news about Innovative Molecules

In short: Innovative Molecules advanced oral adibelivir into Phase 2a and licensed parenteral rights to Alfasigma.

Company announcements

Innovative Molecules

Innovative Molecules raises €20 million in Series A round

The round is led by LSP and the funds will advance the preclinical herpes drug candidate IM-250 into a Phase 2 proof-of-concept study.

Unlock all announcements with a

Media coverage

Finanznachrichten

Innovative Molecules GmbH: Alfasigma Secures Exclusive Rights from Innovative Molecules to Parenteral Adibelivir for Treatment of HSV Encephalitis, an Ultra-Rare Disease

Alfasigma Secures Exclusive Rights from Innovative Molecules to Parenteral Adibelivir for Treatment of HSV Encephalitis, an Ultra-Rare Disease PR Newswire BOLOGNA, Italy and MUNICH, Jan...

Unlock all articles with a

Never miss news about Innovative Molecules

Track Innovative Molecules and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.